Serum amyloid A chemoattracts immature dendritic cells and indirectly provokes monocyte chemotaxis by induction of cooperating CC and CXC chemokines

European Journal of Immunology

Volumn 45, Issue 1, 2015, Pages 101-112

  Gouwy, Mieke ^a   De Buck, Mieke ^a   Pörtner, Noëmie ^a   Opdenakker, Ghislain ^a   Proost, Paul ^a   Struyf, Sofie ^a   Van Damme, Jo ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Chemokines; Chemotaxis; DCs; Monocytes; Serum amyloid A

Indexed keywords

ALPHA CHEMOKINE; BETA CHEMOKINE; CHEMOATTRACTANT; FORMYLMETHIONYLLEUCYLPHENYLALANINE; INTERLEUKIN 1BETA; INTERLEUKIN 8; ISOPROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; NEUTRALIZING ANTIBODY; POLYINOSINIC POLYCYTIDYLIC ACID; RANTES; SERUM AMYLOID A; CCL3 PROTEIN, HUMAN; CCR1 PROTEIN, HUMAN; CCR5 PROTEIN, HUMAN; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR5; CXCL12 PROTEIN, HUMAN; RECOMBINANT PROTEIN; SAA1 PROTEIN, HUMAN; STROMAL CELL DERIVED FACTOR 1;

ARTICLE; CALCIUM SIGNALING; CELL DIFFERENTIATION; CHEMOKINESIS; CHEMOTAXIS; CHEMOTAXIS ASSAY; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; LEUKOCYTE MIGRATION; MONOCYTE; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; SURFACE PROPERTY; AGONISTS; ANTAGONISTS AND INHIBITORS; CELL LINE; CYTOLOGY; DIFFUSION CHAMBER; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; PRIMARY CELL CULTURE; SIGNAL TRANSDUCTION;

ANTIBODIES, NEUTRALIZING; CELL LINE; CHEMOKINE CCL3; CHEMOKINE CXCL12; CHEMOTAXIS; DENDRITIC CELLS; DIFFUSION CHAMBERS, CULTURE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-8; MONOCYTES; PRIMARY CELL CULTURE; RECEPTORS, CCR1; RECEPTORS, CCR5; RECOMBINANT PROTEINS; SERUM AMYLOID A PROTEIN; SIGNAL TRANSDUCTION;

EID: 84920990672     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201444818     Document Type: Article

References (46)

1. Van Damme, J., De Ley, M., Opdenakker, G., Billiau, A., De Somer, P. and Van Beeumen, J., Homogeneous interferon-inducing 22K factor is related to endogenous pyrogen and interleukin-1. Nature 1985. 314: 266-268.
2. 2-terminal sequence-characterized human monokine possessing neutrophil chemotactic, skin-reactive, and granulocytosis-promoting activity. J. Exp. Med. 1988. 167: 1364-1376.
3. Dinarello, C. A., Interleukin-1 and the pathogenesis of the acute-phase response. N. Engl. J. Med. 1984. 311: 1413-1418.
4. Jiang, S. L., Lozanski, G., Samols, D. and Kushner, I., Induction of human serum amyloid A in Hep 3B cells by IL-6 and IL-1 beta involves both transcriptional and post-transcriptional mechanisms. J. Immunol. 1995. 154: 825-831.
5. Larson, M. A., Wei, S. H., Weber, A., Weber, A. T. and McDonald, T. L., Induction of human mammary-associated serum amyloid A3 expression by prolactin or lipopolysaccharide. Biochem. Biophys. Res. Commun. 2003. 301: 1030-1037.
6. Whitehead, A. S., de Beer, M. C., Steel, D. M., Rits, M., Lelias, J. M., Lane, W. S. and de Beer, F. C., Identification of novel members of the serum amyloid A protein superfamily as constitutive apolipoproteins of high density lipoprotein. J. Biol. Chem. 1992. 267: 3862-3867.
7. Badolato, R., Wang, J. M., Murphy, W. J., Lloyd, A. R., Michiel, D. F., Bausserman, L. L., Kelvin, D. J. et al., Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J. Exp. Med. 1994. 180: 203-209.
8. Badolato, R., Johnston, J. A., Wang, J. M., McVicar, D., Xu, L. L., Oppenheim, J. J. and Kelvin, D. J., Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway. J. Immunol. 1995. 155: 4004-4010.
9. Olsson, N., Siegbahn, A. and Nilsson, G., Serum amyloid A induces chemotaxis of human mast cells by activating a pertussis toxin-sensitive signal transduction pathway. Biochem. Biophys. Res. Commun. 1999. 254: 143-146.
10. Patel, H., Fellowes, R., Coade, S. and Woo, P., Human serum amyloid A has cytokine-like properties. Scand. J. Immunol. 1998. 48: 410-418.
11. Xu, L., Badolato, R., Murphy, W. J., Longo, D. L., Anver, M., Hale, S., Oppenheim, J. J. et al., A novel biologic function of serum amyloid A. Induction of T lymphocyte migration and adhesion. J. Immunol. 1995. 155: 1184-1190.
12. Su, S. B., Gong, W., Gao, J. L., Shen, W., Murphy, P. M., Oppenheim, J. J. and Wang, J. M., A seven-transmembrane, G protein-coupled receptor, FPRL1, mediates the chemotactic activity of serum amyloid A for human phagocytic cells. J. Exp. Med. 1999. 189: 395-402.
13. Ye, R. D., Boulay, F., Wang, J. M., Dahlgren, C., Gerard, C., Parmentier, M., Serhan, C. N. et al., International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol. Rev. 2009. 61: 119-161.
14. He, R., Sang, H. and Ye, R. D., Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/LXA4R. Blood 2003. 101: 1572-1581.
15. Jijon, H. B., Madsen, K. L., Walker, J. W., Allard, B. and Jobin, C., Serum amyloid A activates NF-kappaB and proinflammatory gene expression in human and murine intestinal epithelial cells. Eur. J. Immunol. 2005. 35: 718-726.
16. Lee, H. Y., Kim, S. D., Shim, J. W., Lee, S. Y., Lee, H., Cho, K. H., Yun, J. et al., Serum amyloid A induces CCL2 production via formyl peptide receptor-like 1-mediated signaling in human monocytes. J. Immunol. 2008. 181: 4332-4339.
17. Ribeiro, F. P., Furlaneto, C. J., Hatanaka, E., Ribeiro, W. B., Souza, G. M., Cassatella, M. A. and Campa, A., mRNA expression and release of interleukin-8 induced by serum amyloid A in neutrophils and monocytes. Mediators Inflamm. 2003. 12: 173-178.
18. Song, C., Hsu, K., Yamen, E., Yan, W., Fock, J., Witting, P. K., Geczy, C. L. et al., Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes. Atherosclerosis 2009. 207: 374-383.
19. Lee, H. Y., Jo, S. H., Lee, C., Baek, S. H. and Bae, Y. S., Differential production of leukotriene B4 or prostaglandin E2 by WKYMVm or serum amyloid A via formyl peptide receptor-like 1. Biochem. Pharmacol. 2006. 72: 860-868.
20. Baranova, I. N., Vishnyakova, T. G., Bocharov, A. V., Kurlander, R., Chen, Z., Kimelman, M. L., Remaley, A. T. et al., Serum amyloid A binding to CLA-1 (CD36 and LIMPII analogous-1) mediates serum amyloid A protein-induced activation of ERK1/2 and p38 mitogen-activated protein kinases. J. Biol. Chem. 2005. 280: 8031-8040.
21. Bjorkman, L., Karlsson, J., Karlsson, A., Rabiet, M. J., Boulay, F., Fu, H., Bylund, J. et al., Serum amyloid A mediates human neutrophil production of reactive oxygen species through a receptor independent of formyl peptide receptor like-1. J. Leukoc. Biol. 2008. 83: 245-253.
22. Cai, H., Song, C., Endoh, I., Goyette, J., Jessup, W., Freedman, S. B., McNeil, H. P. et al., Serum amyloid A induces monocyte tissue factor. J. Immunol. 2007. 178: 1852-1860.
23. Cheng, N., He, R., Tian, J., Ye, P. P. and Ye, R. D., Cutting edge: TLR2 is a functional receptor for acute-phase serum amyloid A. J. Immunol. 2008. 181: 22-26.
24. Sun, L., Zhu, Z., Cheng, N., Yan, Q. and Ye, R. D., Serum amyloid A induces interleukin-33 expression through an IRF7-dependent pathway. Eur. J. Immunol. 2014. 44: 2153-2164.
25. van der Westhuyzen, D. R., Cai, L., de Beer, M. C. and de Beer, F. C., Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor B-I. J. Biol. Chem. 2005. 280: 35890-35895.
26. Sozzani, S., Dendritic cell trafficking: more than just chemokines. Cytokine Growth Factor Rev. 2005. 16: 581-592.
27. 2-terminal structure. Mol. Pharmacol. 2002. 62: 173-180.
28. Struyf, S., Stoops, G., Van Coillie, E., Gouwy, M., Schutyser, E., Lenaerts, J. P., Fiten, P. et al., Gene cloning of a new plasma CC chemokine, activating and attracting myeloid cells in synergy with other chemoattractants. Biochemistry 2001. 40: 11715-11722.
29. Gouwy, M., Struyf, S., Noppen, S., Schutyser, E., Springael, J. Y., Parmentier, M., Proost, P. et al., Synergy between coproduced CC and CXC chemokines in monocyte chemotaxis through receptor-mediated events. Mol. Pharmacol. 2008. 74: 485-495.
30. Elagoz, A., Henderson, D., Babu, P. S., Salter, S., Grahames, C., Bowers, L., Roy, M. O. et al., A truncated form of CKbeta8-1 is a potent agonist for human formyl peptide-receptor-like 1 receptor. Br. J. Pharmacol. 2004. 141: 37-46.
31. Schutyser, E., Struyf, S., Menten, P., Lenaerts, J. P., Conings, R., Put, W., Wuyts, A. et al., Regulated production and molecular diversity of human liver and activation-regulated chemokine/macrophage inflammatory protein-3 alpha from normal and transformed cells. J. Immunol. 2000. 165: 4470-4477.
32. Chambers, R. E., MacFarlane, D. G., Whicher, J. T. and Dieppe, P. A., Serum amyloid-A protein concentration in rheumatoid arthritis and its role in monitoring disease activity. Ann. Rheum. Dis. 1983. 42: 665-667.
33. Chambers, R. E., Stross, P., Barry, R. E. and Whicher, J. T., Serum amyloid A protein compared with C-reactive protein, alpha 1-antichymotrypsin and alpha 1-acid glycoprotein as a monitor of inflammatory bowel disease. Eur. J. Clin. Invest. 1987. 17: 460-467.
34. Fyfe, A. I., Rothenberg, L. S., de Beer, F. C., Cantor, R. M., Rotter, J. I. and Lusis, A. J., Association between serum amyloid A proteins and coronary artery disease: evidence from two distinct arteriosclerotic processes. Circulation 1997. 96: 2914-2919.
35. Liang, J. S., Sloane, J. A., Wells, J. M., Abraham, C. R., Fine, R. E. and Sipe, J. D., Evidence for local production of acute phase response apolipoprotein serum amyloid A in Alzheimer's disease brain. Neurosci. Lett. 1997. 225: 73-76.
36. Uhlar, C. M. and Whitehead, A. S., Serum amyloid A, the major vertebrate acute-phase reactant. Eur. J. Biochem. 1999. 265: 501-523.
37. Baba, S., Takahashi, T., Kasama, T., Fujie, M. and Shirasawa, H., A novel polymorphism of human serum amyloid A protein, SAA1 gamma, is characterized by alanines at both residues 52 and 57. Arch. Biochem. Biophys. 1993. 303: 361-366.
38. Devosse, T., Guillabert, A., D'Haene, N., Berton, A., De Nadai, P., Noel, S., Brait, M. et al., Formyl peptide receptor-like 2 is expressed and functional in plasmacytoid dendritic cells, tissue-specific macrophage subpopulations, and eosinophils. J. Immunol. 2009. 182: 4974-4984.
39. Migeotte, I., Riboldi, E., Franssen, J. D., Gregoire, F., Loison, C., Wittamer, V., Detheux, M. et al., Identification and characterization of an endogenous chemotactic ligand specific for FPRL2. J. Exp. Med. 2005. 201: 83-93.
40. Yang, D., Chen, Q., Le, Y., Wang, J. M. and Oppenheim, J. J., Differential regulation of formyl peptide receptor-like 1 expression during the differentiation of monocytes to dendritic cells and macrophages. J. Immunol. 2001. 166: 4092-4098.
41. Salogni, L., Musso, T., Bosisio, D., Mirolo, M., Jala, V. R., Haribabu, B., Locati, M. et al., Activin A induces dendritic cell migration through the polarized release of CXC chemokine ligands 12 and 14. Blood 2009. 113: 5848-5856.
42. Sozzani, S., Rieppi, M., Locati, M., Zhou, D., Bussolino, F., Proost, P., Van Damme, J. et al., Synergism between platelet activating factor and C-C chemokines for arachidonate release in human monocytes. Biochem. Biophys. Res. Commun. 1994. 199: 761-766.
43. De Buck, M., Gouwy, M., Proost, P., Struyf, S. and Van Damme, J., Identification and characterization of MIP-1alpha/CCL3 isoform 2 from bovine serum as a potent monocyte/dendritic cell chemoattractant. Biochem. Pharmacol. 2013. 85: 789-797.
44. Wuyts, A., Van Osselaer, N., Haelens, A., Samson, I., Herdewijn, P., Ben-Baruch, A., Oppenheim, J. J. et al., Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties. Biochemistry 1997. 36: 2716-2723.
45. + indicators with greatly improved fluorescence properties. J. Biol. Chem. 1985. 260: 3440-3450.
46. Schutyser, E., Struyf, S., Proost, P., Opdenakker, G., Laureys, G., Verhasselt, B., Peperstraete, L. et al., Identification of biologically active chemokine isoforms from ascitic fluid and elevated levels of CCL18/pulmonary and activation-regulated chemokine in ovarian carcinoma. J. Biol. Chem. 2002. 277: 24584-24593.